News Search Results
May 07, 2025, 13:30 ET Israel's Mileutis Appoints Industry Leaders Dr. Joachim Hasenmaier and Mr. Aaron Schacht to Board of Directors
Aaron Schacht is the CEO of BiomEdit, Inc., a private biotech company backed by the Gates Foundation, which develops microbiome and synthetic biology innovations for animal health. Previously, he led R&D and Business Development at Elanco Animal Health, where he oversaw major acquisitions
More news about: Mileutis Ltd.
May 07, 2025, 11:02 ET GenoFAB Announces Publication of Groundbreaking Self-Documenting Plasmid Technology In Trends In Biotechnology
(970) 817-2400 x800, [email protected] About GenoFAB: GenoFAB is a synthetic biology platform dedicated to helping life scientists write and debug their ideas in DNA. With roots in academic research and a commitment to reproducibility,
More news about: GenoFAB
May 07, 2025, 08:00 ET Invaio Sciences, a Flagship Pioneering Company, Appoints Magalie Guilhabert as Chief Science Officer
overseeing a team of 100 scientists and technicians and managing a $41 million revenue target. Her leadership in synthetic biology, microbial genetics, and data science drove the development of a cutting-edge agricultural solutions portfolio, aligning scientific innovation
More news about: Invaio Sciences
May 06, 2025, 17:00 ET Ginkgo Bioworks Reports First Quarter 2025 Financial Results
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
May 05, 2025, 07:15 ET Atlas Data Storage Announces Initial Close of Seed Financing
extremely high data density, 1,000+ year durability, unlimited low-cost copies, and scalability. The company is spearheading the convergence of synthetic biology and information technology. Atlas' core technology combines novel semiconductor chips and enzyme engineering, ushering in a new era of high-throughput
More news about: Atlas Data Storage
May 02, 2025, 07:30 ET Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
OSRH) focused on the development of design-augmented biologics for regenerative medicine. The company's proprietary platform harnesses synthetic biology and protein engineering to create next-generation growth factors for musculoskeletal and tissue repair. Lead candidates DRT-101 and DRT-102 are
More news about: OSR Holdings Inc.
Apr 30, 2025, 09:00 ET Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Apr 26, 2025, 21:40 ET Bestzyme's Mellia™ Brazzein Receives FDA "No Questions" Letter, Bringing Creative Sugar Reduction Solution to Global Market
research, development, and industrialization of enzymes, functional proteins, and biopharmaceutical raw materials. By leveraging its proprietary synthetic biology technology platform, Bestzyme has established a comprehensive system covering molecular design, strain engineering, and process scaling. The company
More news about: GenScript Biotech Corporation
Apr 22, 2025, 09:00 ET Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Apr 17, 2025, 06:00 ET GMO/Toxin Free USA Sues Perfect Day Alleging Misleading Claims About "Animal Free Dairy"
"whey protein" used by brands such as Bored Cow Animal-Free Dairy Milk and Myprotein Whey Forward Animal Free Protein. ProFerm is made using synthetic biology (synbio) genetic engineering. The industry describes the process as "precision fermentation." Perfect Day and brand partners market ProFerm
More news about: GMO/Toxin Free USA
Apr 16, 2025, 07:17 ET 28 CAPITAL LAUNCHES NEW VENTURE TO ADVANCE SCIENTIFIC BREAKTHROUGHS FOR PATIENTS
first venture gave rise to a portfolio of transformative biotech companies—including platform technologies in therapeutics, diagnostics, and synthetic biology. 28 Capital partners closely with academic founders, top-tier institutions, and PIs to identify foundational science and turn it into scalable,
More news about: 28 Capital
Apr 10, 2025, 09:00 ET Accelerating agrigenomics: Daicel Arbor Biosciences and Element Biosciences announce new grant opportunity
April 10, 2025 /PRNewswire/ -- Daicel Arbor Biosciences, a company that offers tools and services to accelerate genomics and synthetic biology research, in collaboration with
More news about: Daicel Arbor Biosciences
Apr 10, 2025, 09:00 ET Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain
[email protected] About Tritica Bio At Tritica Biosciences, we are revolutionizing synthetic biology through a groundbreaking technology designed for rapid discovery, prototyping, and manufacturing, with applications from farm to pharma. Our focus
More news about: Ginkgo Bioworks
Apr 07, 2025, 09:00 ET Rise Therapeutics Reports Ulcerative Colitis Dose Escalation Clinical Results for R-3750 at the Digestive Disease Week (DDW) Conference in San Diego May 3-6
R-3750, a novel oral immunotherapy, is a synthetic biology-based medicine in development for the treatment of Inflammatory Bowel Disease (IBD). Optimized to selectively target dendritic cells, R-3750 is
More news about: Rise Therapeutics
Apr 03, 2025, 08:49 ET Chan Zuckerberg Biohub New York Announces New Investigators for Immune System Research to Improve Human Health
including neurodegenerative disorders and aggressive cancers. The funded projects support a variety of innovative strategies, including leveraging synthetic biology to address the limitations of current immune cell therapies and using models to enable insights into cellular networks and tissue adaptations
More news about: Chan Zuckerberg Biohub New York
Apr 03, 2025, 02:46 ET Kanazawa University research: Live imaging captures DNA folding in sperm cells for the first time
Gene therapy might improve through a better understanding of DNA compaction and its role in genetic material delivery in medical treatments. Synthetic biology and nanotechnology could also leverage these findings to develop new methods for manipulating DNA structures in biotechnological applications.
More news about: Kanazawa University